MACROGENICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
MACROGENICS, INC. (MGNX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 15.61 million shares for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2025-11-12
- MACROGENICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 15.61M shares, a 9.65% increase year-over-year.
- MACROGENICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-09-30 was 14.24M shares, a 12.92% increase year-over-year.
- MACROGENICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-09-30 was 12.61M shares.
- MACROGENICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-06-30 was 12.56M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed |
|---|---|---|---|---|---|
| 2025-09-30 | 15.61M shares 10-Q · filed 2025-11-12 | ||||
| 2024-09-30 | 14.24M shares 10-Q · filed 2025-11-12 | ||||
| 2023-09-30 | 12.61M shares 10-Q · filed 2024-11-05 | 12.51M shares 10-Q · filed 2024-11-05 | |||
| 2023-06-30 | 12.56M shares 10-Q · filed 2023-08-09 | 12.24M shares 10-Q · filed 2023-08-09 | |||
| 2018-09-30 | 5.35M shares 10-Q · filed 2018-11-07 | 5.35M shares 10-Q · filed 2018-11-07 | |||
| 2018-06-30 | 5.37M shares 10-Q · filed 2018-08-07 | 5.37M shares 10-Q · filed 2018-08-07 | |||
| 2018-03-31 | 5.32M shares 10-Q · filed 2018-05-07 | ||||
| 2017-09-30 | 4.53M shares 10-Q · filed 2018-11-07 | 4.53M shares 10-Q · filed 2018-11-07 | |||
| 2017-06-30 | 4.62M shares 10-Q · filed 2018-08-07 | 4.62M shares 10-Q · filed 2018-08-07 | |||
| 2017-03-31 | 4.74M shares 10-Q · filed 2018-05-07 | ||||
| 2016-09-30 | 3.86M shares 10-Q · filed 2017-11-08 | 1.46M shares 10-Q · filed 2016-11-02 | 3.86M shares 10-Q · filed 2017-11-08 | 1.42M shares 10-Q · filed 2016-11-02 | |
| 2016-06-30 | 257.68K shares 10-Q · filed 2017-08-02 | 114.15K shares 10-Q · filed 2017-08-02 | |||
| 2016-03-31 | 4.02M shares 10-Q · filed 2017-05-03 | 1.42M shares 10-Q · filed 2016-05-04 | |||
| 2015-09-30 | 1.92M shares 10-Q · filed 2016-11-02 | 911.30K shares 10-Q · filed 2016-11-02 | |||
| 2015-06-30 | 2.02M shares 10-Q · filed 2016-08-03 | 738.88K shares 10-Q · filed 2016-08-03 | |||
| 2015-03-31 | 2.72M shares 10-Q · filed 2016-05-04 | ||||
| 2014-09-30 | 2.26M shares 10-Q · filed 2015-11-04 | 2.27M shares 10-Q · filed 2015-11-04 | |||
| 2014-06-30 | 2.27M shares 10-Q · filed 2015-08-05 | 2.38M shares 10-Q · filed 2015-08-05 | |||
| 2014-03-31 | 2.72M shares 10-Q · filed 2015-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |